MLAB vs NOVT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

MLAB

45.5
AI Score
VS
NOVT Wins

NOVT

45.9
AI Score

Investment Advisor Scores

MLAB

46score
Recommendation
HOLD

NOVT

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MLAB NOVT Winner
Revenue 122.47M 828.52M NOVT
Net Income 7.17M 35.66M NOVT
Gross Margin 64.4% 44.7% MLAB
Net Margin 5.9% 4.3% MLAB
Operating Income 15.42M 59.51M NOVT
ROE 3.7% 2.2% MLAB
ROA 1.8% 1.1% MLAB
Total Assets 407.74M 3.17B NOVT
Cash 22.31M 149.22M NOVT
Debt/Equity 0.33 0.48 MLAB
Current Ratio 1.90 1.18 MLAB
Free Cash Flow 17.89M 135.31M NOVT

Relative Price Performance (Last 90 Days)

MLAB 1M: +11.4% · 3M: +25.6% NOVT 1M: -14.3% · 3M: -25.4%

Current Technical Phase

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 64

RSI (14): 64.1 · Price: $142.17

NOVT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.9%), weak momentum, RSI 39

RSI (14): 38.8 · Price: $124.76

Fundamentals Snapshot

Metric MLAB NOVT
Market Cap — —
Forward P/E 25.4 28.3
Trailing P/E 150.4 92.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.6% 0.4%
Operating Margin 0.1% 0.0%
EPS 0.85 1.58
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, NOVT is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.